796 results on '"Selek, Ugur"'
Search Results
2. The Predictive Power of Biomarkers in Osteoradionecrosis
3. Comment on Konishi et al.
4. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers
5. Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas
6. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients
7. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network
8. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer
9. In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)
10. Valero’s host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients
11. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
12. Comment on: Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer
13. Radiation Therapy for Lung Cancer in Elderly
14. Mechanisms of Action of Radiotherapy and Immunotherapy in Lung Cancer: Implications for Clinical Practice
15. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients
16. Comment on: Intensity Modulated Radiotherapy in Head and Neck Cancer: Initial Experience of the First Treated Cases from North-East India
17. Radiotherapy and Dental Implant Applications in Patients with Head and Neck Cancer
18. In Regard to Xu et al
19. Oral Microbiota: As a Cause of Head and Neck Cancers
20. Preoperative Radiosurgical Management of Brain Metastases: Evidence and Challenges
21. Combined Stereotactic Radiosurgery and Immune Checkpoint Inhibitors for the Treatment of Brain Metastasis
22. Esophageal cancer
23. In Reference to Amina et al (2022) Titled: ‘Radiation Therapy Treatment Outcomes for Patients with Head and Neck Cancer: A Tertiary Care Centre Experience in a Tier Three Town’ (doi: 10.1007/s12070-021-02810-7)
24. A novel and clinically useful weight-optimized dynamic conformal arc in stereotactic radiation therapy of non-small cell lung cancer: Dosimetric comparison of treatment plans with volumetric‐modulated arc therapy
25. Definitions of Radiation-induced Trismus in Head and Neck Cancer: Current Concepts and Controversies
26. Challenges in the Radiological Diagnosis of Osteoradionecrosis of the Jaw in Head and Neck Cancer Patients
27. Assessment of the Impact of Osteoradionecrosis on Quality-of-Life Measures in Patients with Head and Neck Cancer
28. Global immune-nutrition-inflammation index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients
29. In Reference to Treatment Outcome in Head and Neck Cancer with Distant Metastasis at Initial Diagnosis
30. Comment on Sasaki et al. (https://doi.org/10.1111/odi.14865)
31. Comment on Frydrych et al. (https://doi.org/10.1111/odi.14837)
32. Causes of Delays in Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients
33. Comment on Survivin -31G/C polymorphism and disease fate in of oral squamous cell carcinomas
34. Letter to the Editor regarding “The influence of antibiotic administration on the outcomes of head‐and‐neck squamous cell carcinoma patients undergoing definitive (chemo)radiation” by Rühle et al.
35. Radiation-induced Trismus and Related Measures of Patient Life Quality
36. Radiation- Induced Trismus: A Concise Review of Pathogenesis, Prevention and Management
37. Toxicity Management for Pelvic Tumors in Radiation Oncology
38. Persistent Inflammation as a Cause of Severe Late Complications in Chemoradiotherapy-treated Head and Neck Cancer Patients
39. Novel Somay's GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis.
40. Lymphoma
41. Breast Cancer
42. Lung Cancer
43. Head and Neck Cancers
44. Mechanisms of Action of Radiotherapy and Immunotherapy in Lung Cancer: Implications for Clinical Practice
45. Radiation Therapy for Lung Cancer in Elderly
46. Response to Deantoni et al.
47. Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
48. Tooth Extraction and Osteoradionecrosis
49. Re: Minimum detectable change in occlusal load – Normative data for healthy and head and neck cancer populations
50. Comment on Prospective Study to Compare Efficacy of Conventional Chemoradiotherapy with Hypofractionated Chemoradiotherapy in Locally Advanced Carcinoma of Oropharynx
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.